Search
for
Sort by
Research 781–810 of 1000+
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- PSS34 THE IMPACT OF POTENTIAL PILL SPLITTING ON GENERIC AND BRANDED FINASTERIDE UPTAKE
- Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- Nutritional Pharmacology and Mechanistic Insights of Saw Palmetto in Male Endocrine and Prostatic Disorders
- Nutritional Pharmacology and Mechanistic Insights of Saw Palmetto in Male Endocrine and Prostatic Disorders
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- MP11-05 THE UROLOGIC IMPACT OF LONG-TERM FINASTERIDE-1 MG USE FOR ANDROGENIC ALOPECIA: A MATCHED-COHORT DATABASE ANALYSIS
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Protective role of hesperidin in finasteride-induced testicular toxicity in adult male Wistar rats: Insights into oxidative stress, apoptosis, and ultrastructure of seminiferous tubules
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- O impacto da COVID-19 no ciclo menstrual: uma perspectiva geral
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- The association between androgenic alopecia severity and the development of metabolic syndrome in Saudi Arabia: A case-control study
- Editorial Comment
- P4‐276: A case of apparently reversible Alzheimer's disease
- An improved synthesis of finasteride from 4-androsten-3,17-dione
- T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Elaboration of hollow mesoporous organosilica nanospheres of various sizes
- Bioactive metabolites of edible mushrooms efficacious against androgenic alopecia: Targeting SRD5A2 using computational approach
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade”
- AB089. What should we know role of finasteride in erectile dysfunction?
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Faculty Opinions recommendation of Persistent sexual side effects of finasteride for male pattern hair loss.
- USE OF ALOE IIM TREATING LEG ULCERS AND DERMATOSES